- Report
- May 2022
- 310 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- May 2022
- 236 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- April 2022
- 136 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- October 2022
- 220 Pages
Global
From €3394EUR$3,570USD£2,851GBP
Sarcoma is a type of cancer that affects the connective tissues of the body, such as muscle, bone, fat, and blood vessels. Sarcoma drugs are used to treat this type of cancer, and are part of the larger oncology drug market. These drugs are typically used in combination with other treatments, such as surgery, radiation, and chemotherapy. Sarcoma drugs are designed to target the specific type of cancer, and can be used to reduce the size of tumors, slow the growth of cancer cells, and reduce the risk of metastasis.
The sarcoma drug market is highly competitive, with many companies developing new treatments and therapies. Some of the major players in the market include Pfizer, Merck, Novartis, Bristol-Myers Squibb, and Eli Lilly. Other companies, such as Amgen, AstraZeneca, and Celgene, are also developing treatments for sarcoma. Show Less Read more